-
1
-
-
85035392112
-
Liver fibrosis
-
1:CAS:528:DC%2BD2MXhtFyjs70%3D 15690074
-
R Bataller DA Brenner 2005 Liver fibrosis J Clin Invest 115 209 218 1:CAS:528:DC%2BD2MXhtFyjs70%3D 15690074
-
(2005)
J Clin Invest
, vol.115
, pp. 209-218
-
-
Bataller, R.1
Brenner, D.A.2
-
2
-
-
13844306623
-
Hepatic fibrosis: Molecular mechanisms and drug targets
-
DOI 10.1146/annurev.pharmtox.45.120403.095906
-
S Lotersztajn B Julien F Teixeira-Clerc P Grenard A Mallat 2005 Hepatic fibrosis: molecular mechanisms and drug targets Annu Rev Pharmacol Toxicol 45 605 628 10.1146/annurev.pharmtox.45.120403.095906 10.1146/annurev.pharmtox.45. 120403.095906 1:CAS:528:DC%2BD2MXisVWjtLc%3D 15471534 (Pubitemid 40261819)
-
(2005)
Annual Review of Pharmacology and Toxicology
, vol.45
, pp. 605-628
-
-
Lotersztajn, S.1
Julien, B.2
Teixeira-Clerc, F.3
Grenard, P.4
Mallat, A.5
-
3
-
-
0037220482
-
Liver fibrosis - From bench to bedside
-
DOI 10.1016/S0168-8278(02)00429-4
-
SL Friedman 2003 Liver fibrosis: from bench to bedside J Hepatol 38 S38 S53 10.1016/S0168-8278(02)00429-4 10.1016/S0168-8278(02)00429-4 12591185 (Pubitemid 39658635)
-
(2003)
Journal of Hepatology
, vol.38
, Issue.SUPPL. 1
-
-
Friedman, S.L.1
-
4
-
-
0036219609
-
Hsp90 inhibitors as novel cancer chemotherapeutic agents
-
DOI 10.1016/S1471-4914(02)02316-X, PII S147149140202316X
-
L Neckers 2002 Hsp90 inhibitors as novel cancer chemotherapeutic agents Trends Mol Med 8 S55 S61 10.1016/S1471-4914(02)02316-X 10.1016/S1471-4914(02) 02316-X 1:CAS:528:DC%2BD38XitlGhsb4%3D 11927289 (Pubitemid 34297080)
-
(2002)
Trends in Molecular Medicine
, vol.8
-
-
Neckers, L.1
-
5
-
-
33846861747
-
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
-
DOI 10.1677/erc.1.01324
-
MV Powers P Workman 2006 Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors Endocr Relat Cancer 131 S125 S135 10.1677/erc.1.01324 10.1677/erc.1.01324 (Pubitemid 46219254)
-
(2006)
Endocrine-Related Cancer
, vol.13
, Issue.SUPPL. 1
-
-
Powers, M.V.1
Workman, P.2
-
6
-
-
0037040975
-
The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation
-
DOI 10.1074/jbc.M109200200
-
N Grammatikakis A Vultur CV Ramana A Siganou CW Schweinfest DK Watson L Raptis 2002 The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation J Biol Chem 277 8312 8320 10.1074/jbc.M109200200 10.1074/jbc.M109200200 1:CAS:528:DC%2BD38XitFymt7s%3D 11751906 (Pubitemid 34968291)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.10
, pp. 8312-8320
-
-
Grammatikakis, N.1
Vultur, A.2
Ramana, C.V.3
Siganou, A.4
Schweinfest, C.W.5
Watson, D.K.6
Raptis, L.7
-
7
-
-
0742287264
-
Heat shock protein 90
-
DOI 10.1097/00001622-200311000-00003
-
L Neckers SP Ivy 2003 Heat shock protein 90 Curr Opin Oncol 15 419 424 10.1097/00001622-200311000-00003 10.1097/00001622-200311000-00003 1:CAS:528:DC%2BD3sXptVCmsbg%3D 14624223 (Pubitemid 38147036)
-
(2003)
Current Opinion in Oncology
, vol.15
, Issue.6
, pp. 419-424
-
-
Neckers, L.1
Ivy, S.P.2
-
8
-
-
33644835965
-
Heat shock proteins in cancer: Chaperones of tumorigenesis
-
DOI 10.1016/j.tibs.2006.01.006, PII S0968000406000272
-
SK Calderwood MA Khaleque DB Sawyer DR Ciocca 2006 Heat shock proteins in cancer: chaperones of tumorigenesis Trends Biochem Sci 31 164 172 10.1016/j.tibs.2006.01.006 10.1016/j.tibs.2006.01.006 1:CAS:528: DC%2BD28Xit1ymsL4%3D 16483782 (Pubitemid 43361923)
-
(2006)
Trends in Biochemical Sciences
, vol.31
, Issue.3
, pp. 164-172
-
-
Calderwood, S.K.1
Khaleque, M.A.2
Sawyer, D.B.3
Ciocca, D.R.4
-
9
-
-
1142273472
-
Altered states: Selectively drugging the Hsp90 cancer chaperone
-
DOI 10.1016/j.molmed.2003.12.005
-
P Workman 2004 Altered states: selectively drugging the Hsp90 cancer chaperone Trends Mol Med 10 47 51 10.1016/j.molmed.2003.12.005 10.1016/j.molmed.2003.12.005 1:CAS:528:DC%2BD2cXhtFWjsLg%3D 15106614 (Pubitemid 38210022)
-
(2004)
Trends in Molecular Medicine
, vol.10
, Issue.2
, pp. 47-51
-
-
Workman, P.1
-
10
-
-
26444482073
-
Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models
-
DOI 10.1158/1078-0432.CCR-05-0518
-
U Banerji M Walton F Raynaud R Grimshaw L Kelland M Valenti I Judson P Workman 2005 Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models Clin Cancer Res 11 7023 7032 10.1158/1078-0432.CCR-05-0518 10.1158/1078-0432.CCR-05-0518 1:CAS:528: DC%2BD2MXhtVKiurjP 16203796 (Pubitemid 41428762)
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 7023-7032
-
-
Banerji, U.1
Walton, M.2
Raynaud, F.3
Grimshaw, R.4
Kelland, L.5
Valenti, M.6
Judson, I.7
Workman, P.8
-
11
-
-
21244505104
-
Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design
-
DOI 10.1021/jm050355z
-
BW Dymock X Barril PA Brough, et al. 2005 Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design J Med Chem 48 4212 4215 10.1021/jm050355z 10.1021/jm050355z 1:CAS:528:DC%2BD2MXkslSnsbg%3D 15974572 (Pubitemid 40884922)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.13
, pp. 4212-4215
-
-
Dymock, B.W.1
Barril, X.2
Brough, P.A.3
Cansfield, J.E.4
Massey, A.5
McDonald, E.6
Hubbard, R.E.7
Surgenor, A.8
Roughley, S.D.9
Webb, P.10
Workman, P.11
Wright, L.12
Drysdale, M.J.13
-
12
-
-
0027251069
-
Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43
-
1:CAS:528:DyaK2cXhsF2ls7o%3D 8394478
-
P Greenwel J Rubin M Schwartz EL Hertzberg M Rojkind 1993 Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43 Lab Invest 69 210 217 1:CAS:528: DyaK2cXhsF2ls7o%3D 8394478
-
(1993)
Lab Invest
, vol.69
, pp. 210-217
-
-
Greenwel, P.1
Rubin, J.2
Schwartz, M.3
Hertzberg, E.L.4
Rojkind, M.5
-
13
-
-
27744471940
-
The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-β and TNF-α in human breast cancer cells
-
DOI 10.1093/carcin/bgi154
-
JX Kang J Liu J Wang C He FP Li 2005 The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells Carcinogenesis 26 1934 1939 10.1093/carcin/bgi154 10.1093/carcin/bgi154 1:CAS:528: DC%2BD2MXhtFCjt73E 15958519 (Pubitemid 41631267)
-
(2005)
Carcinogenesis
, vol.26
, Issue.11
, pp. 1934-1939
-
-
Kang, J.X.1
Liu, J.2
Wang, J.3
He, C.4
Li, F.P.5
-
14
-
-
0035375995
-
Reversibility of hepatic fibrosis: From the first report of collagenase in the liver to the possibility of gene therapy for recovery
-
1:CAS:528:DC%2BD3MXmsV2ksrc%3D 11450593
-
I Okazaki T Watanabe S Hozawa M Niioka M Arai K Maruyama 2001 Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery Keio J Med 50 58 65 1:CAS:528:DC%2BD3MXmsV2ksrc%3D 11450593
-
(2001)
Keio J Med
, vol.50
, pp. 58-65
-
-
Okazaki, I.1
Watanabe, T.2
Hozawa, S.3
Niioka, M.4
Arai, M.5
Maruyama, K.6
-
15
-
-
42949163491
-
Mechanisms of hepatic fibrogenesis
-
DOI 10.1053/j.gastro.2008.03.003, PII S0016508508004290
-
SL Friedman 2008 Mechanisms of hepatic fibrogenesis Gastroenterology 134 1655 1669 10.1053/j.gastro.2008.03.003 10.1053/j.gastro.2008.03.003 1:CAS:528:DC%2BD1cXntF2gs7o%3D 18471545 (Pubitemid 351615417)
-
(2008)
Gastroenterology
, vol.134
, Issue.6
, pp. 1655-1669
-
-
Friedman, S.L.1
-
16
-
-
1642268986
-
Hsp90 isoforms: Functions, expression and clinical importance
-
DOI 10.1016/S0014-5793(04)00229-7, PII S0014579304002297
-
AS Sreedhar E Kalmár P Csermely YF Shen 2004 Hsp90 isoforms: functions, expression and clinical importance FEBS Lett 562 11 15 10.1016/S0014-5793(04)00229-7 10.1016/S0014-5793(04)00229-7 15069952 (Pubitemid 38388440)
-
(2004)
FEBS Letters
, vol.562
, Issue.1-3
, pp. 11-15
-
-
Sreedhar, A.S.1
Kalmar, E.2
Csermely, P.3
Shen, Y.-F.4
-
17
-
-
7444261000
-
Interferon-α acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-α by an HSP70-dependant pathway
-
DOI 10.1078/0171-9335-00409
-
B Saile C Eisenbach J Dudas H El-Armouche G Ramadori 2004 Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway Eur J Cell Biol 83 469 476 10.1078/0171-9335-00409 10.1078/0171-9335-00409 1:CAS:528:DC%2BD2cXhtFaktbrJ 15540463 (Pubitemid 39439959)
-
(2004)
European Journal of Cell Biology
, vol.83
, Issue.9
, pp. 469-476
-
-
Saile, B.1
Eisenbach, C.2
Dudas, J.3
El-Armouche, H.4
Ramadori, G.5
-
18
-
-
0037424498
-
The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type i collagen expression
-
10.1074/jbc.M212927200 10.1074/jbc.M212927200
-
S Reif A Lang JN Lindquist, et al. 2004 The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression J Biol Chem 278 8083 8090 10.1074/jbc.M212927200 10.1074/jbc.M212927200
-
(2004)
J Biol Chem
, vol.278
, pp. 8083-8090
-
-
Reif, S.1
Lang, A.2
Lindquist, J.N.3
-
19
-
-
38349157746
-
4,5-Diarylisoxazole Hsp90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
-
10.1021/jm701018h 10.1021/jm701018h 1:CAS:528:DC%2BD2sXhtlWqsL%2FK 18020435
-
PA Brough W Aherne X Barril, et al. 2008 4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer J Med Chem 51 196 218 10.1021/jm701018h 10.1021/jm701018h 1:CAS:528: DC%2BD2sXhtlWqsL%2FK 18020435
-
(2008)
J Med Chem
, vol.51
, pp. 196-218
-
-
Brough, P.A.1
Aherne, W.2
Barril, X.3
|